fatty diacid chain raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-12 and is reviewed periodically as new material appears.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | 31 amino acid residues |
| Molecular formula | C187H291N45O59 | free peptide, no counter-ion |
| Approximate mass | 4114 Da | matches theoretical value |
| Receptor target | Glucagon-like peptide-1 receptor | Gs-coupled, cyclic AMP pathway |
| Circulation half-life | About one week in humans | extended by albumin association |
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
=== Part One === Part One is set during the second half of events of Half-Life 2: Episode One. Dr. Isaac Kleiner is making his "Kleinercasts" on City 17's PA system, warning that the Combine Citadel is set to explode at any moment; should the Citadel detonate, the resulting explosion will destroy the city and the surrounding area. Prior to the film's events, Gordon Freeman's actions within the Citadel have held down the impending explosion, opening a small window of time for civilians to escape. Members of the Lambda Resistance are seen fighting their way out of the city as the Combine's Civil Protection forces try to hold them back. CP officers are also seen executing captured rebels, while Combine synths wreak havoc on the warzone. Two male Resistance members (Derek Chan and Ian Purchase) are introduced escaping through an overrun trainyard. Through radio communication, the two learn from a third rebel (David Purchase) that the last evacuation train has already left, and are urged to escape the city on foot through the canal system (a route similar to that of Gordon Freeman's in Half-Life 2) in order to catch up with David, who is en route to the Resistance stronghold of White Forest. After a brief argument, the two resolve to escape City 17 before "the Citadel blows us up first". Suddenly, CP officers appear and fire on the Resistance members. The two retaliate with their own weaponry (Derek using a 9mm pistol, then a crowbar found hanging on a handrail; Ian using an SMG with a grenade launcher) and manage to escape.
(CH2CH2)O + CH3CONH2 → HOCH2CH2NHC(O)CH3 Addition of ethylene oxide to higher carboxylic acids is carried out at elevated temperatures (typically 140–180 °C (284–356 °F)) and pressure (0.3–0.5 MPa (44–73 psi)) in an inert atmosphere, in presence of an alkaline catalyst (concentration 0.01–2%), such as hydroxide or carbonate of sodium or potassium. The carboxylate ion acts as nucleophile in the reaction:
Peter Burke (born 1937) historian, professor and author of over twenty scholarly academic texts and monographs on European history, epistemology, ontology, prisms and perspectives on historiography and ideology; born to Roman Catholic father and Jewish mother (who later converted to Roman Catholicism); was member of School of European Studies at University of Sussex, before moving to University of Cambridge, where he holds title of Professor Emeritus of Cultural History and Fellow of Emmanuel College, Cambridge; celebrated as historian not only of early modern era, but one who emphasises relevance of social and cultural history to modern issues; in 1998, was awarded the Erasmus Medal of the European Academy, and is an honorary doctorate from the Universities of Lund, Copenhagen and Bucharest. Elias Canetti novelist, man of letters, 1981 Nobel Prize (Bulgarian-born); most famous for his work on mass psychology of crowds and anti-fascism, Crowds and Power David Cesarani (13 November 1956 – 25 October 2015) British historian who specialised in Jewish history, especially the Holocaust. He also wrote several biographies, including Arthur Koestler: The Homeless Mind (1998).
Sources: en.wikipedia.org
Neanderthals collected non-functional, uniquely-shaped objects, namely shells, fossils, and gems. It is unclear if these objects were simply picked up for their aesthetic qualities, or if some symbolic significance was applied to them. Some shells may have been painted. Gibraltarian palaeoanthropologists Clive and Geraldine Finlayson suggested that Neanderthals used various bird parts as artistic media, especially black feathers. A 2020 study found evidence of a 3-ply cord fragment made from conifer inner-bark fibres at Abri du Maras, France, which can be used to knit light items, such as strings for hanging beads. 115,000-year-old perforated shell beads from Cueva Antón were possibly strung together to make a necklace. There are several instances of nondescript engravings and scratches on flints, bones, pebbles, and stone slabs — as of 2014, 63 purported engravings have been reported from 27 different European and Middle Eastern Lower-to-Middle Palaeolithic sites. It is debated if these were made with symbolic intent. Neanderthals may have produced finger flutings on the walls of La Roche-Cotard over 57,000 years ago. Neanderthals used ochre, a clay earth pigment. It is unclear if this constitutes evidence of artmaking because, while modern humans have used red ochre for decorative or symbolic colouration, they have also used ochre as medicine, hide tanning agent, food preservative, and insect repellent.
The kanji phrase 銀杏 ginkyō meaning 'silver apricot' had been attested in Chinese herbology literature such as 日用本草 (Daily Use Materia Medica) (1329) and Compendium of Materia Medica 本草綱目 published in 1578; 銀杏 was particular terminology used during the Song dynasty for tributary reasons in place of the then contemporary 鴨脚 ("duckfeet", from its leaves) in northeast China where it commonly grew. The older Chinese name for this plant is 銀果, meaning "silver fruit", pronounced yínguǒ in Mandarin or ngan-gwo in Cantonese, the current commonly used names are 白果 (bái guǒ) meaning 'white fruit'. Despite its spelling based on this complicated etymology, "ginkgo" is usually pronounced , which has given rise to the common alternative spelling "gingko". The spelling pronunciation is also documented in some dictionaries.
At microwave frequencies, the first, imperfect invisibility cloak was realized in 2006. From the standpoint of governing equations, contemporary researchers can classify the realm of metamaterials into three primary branches: Electromagnetic/Optical wave metamaterials, other wave metamaterials, and diffusion metamaterials. These branches are characterized by their respective governing equations, which include Maxwell's equations (a wave equation describing transverse waves), other wave equations (for longitudinal and transverse waves), and diffusion equations (pertaining to diffusion processes). Crafted to govern a range of diffusion activities, diffusion metamaterials prioritize diffusion length as their central metric. This crucial parameter experiences temporal fluctuations while remaining immune to frequency variations. In contrast, wave metamaterials, designed to adjust various wave propagation paths, consider the wavelength of incoming waves as their essential metric. This wavelength remains constant over time, though it adjusts with frequency alterations. Fundamentally, the key metrics for diffusion and wave metamaterials present a stark divergence, underscoring a distinct complementary relationship between them. For comprehensive information, refer to Section I.B, "Evolution of metamaterial physics," in Ref.
==== Phenylketonuria ==== Individuals with phenylketonuria (PKU) must keep their intake of phenylalanine – an essential amino acid – extremely low to prevent a mental disability and other metabolic complications. Phenylalanine is a component of the artificial sweetener aspartame, so people with PKU need to avoid low calorie beverages and foods with this ingredient.
Sources: en.wikipedia.org
== Work == Born in Melbourne, Australia, Bottomley earned a BSc in physics from Monash University in Australia in 1974. In 1975, he started his PhD in physics at the University of Nottingham in England, in one of the three original groups that began MRI. In Raymond Andrew's group, alongside that of Peter Mansfield, they built the first MRI system producing radiographic-quality images of the human wrist, and he performed the initial work on RF-field and power deposition in human MRI. Upon completing his PhD in 1978, he went to Johns Hopkins University in Baltimore in the USA to adapt MRI methods for spatially localizing MRS signals, initially using surface coils to demonstrate localized metabolite depletion and reversal in regional myocardial ischemia in vivo. In 1980, Paul joined the GE Research Center in Schenectady NY. Together with William A. Edelstein and others, this group began GE's entry into MRI technology. They ordered the biggest magnet available at the time – a 1.5 tesla system – and built the first high-field whole-body MRI/MRS scanner, overcoming problems of coil design, RF penetration and signal-to-noise concerns. The results translated into the highly successful 1.5 tesla clinical MRI products of which there are well over 20,000 systems today, representing 60-70% of all systems. Using a combination of switched MRI localizing magnetic field gradients with MRS acquisition, Paul and his colleagues performed the first noninvasive localized MRS of the human heart and brain.
== See also == Ancient DNA Biocultural anthropology Biological distance analysis Odontometrics Osteoarchaeology Paleopathology Zooarchaeology 2025 in bioarchaeology 2026 in bioarchaeology Dental analysis in archaeology
== Awards == Prix scientifique de la Fondation de France, with André Langaney, 1978 Prix de la Société française de physique, 1985 Le Relictocarabus meurguesianus, and insect discovered in Morocco, was named in her honour.
Amyloid-related imaging abnormalities (ARIA) are abnormal differences seen in magnetic resonance imaging of the brain in patients with Alzheimer's disease. ARIA is associated with anti-amyloid drugs, particularly human monoclonal antibodies such as aducanumab. There are two types of ARIA: ARIA-E and ARIA-H. The phenomenon was first seen in trials of bapineuzumab. ARIA-E refers to cerebral edema, involving the breakdown of the tight endothelial junctions of the blood-brain barrier and subsequent accumulation of fluid. In a double-blind trial of the humanised monoclonal antibody solanezumab (n = 2042), sixteen patients (11 taking the drug, 5 taking a placebo), or 0.78% developed ARIA-E. A further 7 patients developed ARIA-E during an open-label extension of the trial. The effect of ARIA-E depends on the severity and location of the edema. Symptoms may include headache, changes in mental state, confusion, vomiting, nausea, tremor and gait disturbances.
An important structural component of RNA that distinguishes it from DNA is the presence of a hydroxyl group at the 2' position of the ribose sugar. The presence of this functional group causes the helix to mostly take the A-form geometry, although in single strand dinucleotide contexts, RNA can rarely also adopt the B-form most commonly observed in DNA. The A-form geometry results in a very deep and narrow major groove and a shallow and wide minor groove. A second consequence of the presence of the 2'-hydroxyl group is that in conformationally flexible regions of an RNA molecule (that is, not involved in formation of a double helix), it can chemically attack the adjacent phosphodiester bond to cleave the backbone.
Sources: en.wikipedia.org
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.
The substitution at position 8 removes the site recognised by dipeptidyl peptidase-4, the enzyme that destroys the native hormone within minutes. The linked lipophilic chain then binds circulating albumin, which further limits access by degradative enzymes and reduces renal loss. Together these features lengthen the effective circulation time considerably.
It acts at the glucagon-like peptide-1 receptor, a G protein-coupled receptor that signals mainly through cyclic AMP. Activation is glucose dependent, meaning insulin release is stimulated more strongly when blood glucose is already elevated. Other tissues carrying the same receptor respond as well, which explains effects beyond glucose control.
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and cleared quickly. Semaglutide carries a position 8 substitution that blocks that cleavage and a fatty diacid chain that binds albumin. Together these changes extend its circulating half-life to about one week.